Communiqués Faron Pharmaceuticals Oy

Actions

Temps Différé London S.E. Autres places de cotation 10:34:51 06/06/2024			Varia. 5j.	Varia. 1 janv.
100,8 ^GBX	-2,14 %		-43,21 %	-66,95 %

04/06	Faron Pharmaceuticals va lancer une offre d'actions de 31 millions d'euros	MT
04/06	GAGNANTS ET PERDANTS DE L'OBJECTIF : Vast Resources vante les progrès réalisés dans les mines	AN

Proposed REX Retail Offer	05/06	AQ
Faron commences a share offering	04/06	AQ
Faron Pharmaceuticals Oy - Issuance of warrants	20/05	AQ
Initial positive data from Phase 2 of BEXMAB	20/05	AQ
Issuance of warrants	17/05	AQ
Faron Founders and bexmarilimab Developers Selected as Finalists for the European Inventor Award 2024	16/05	AQ
Founders named European Inventor Award finalists	16/05	AQ
Replacement - Board Change	13/05	AQ
Faron Pharmaceuticals' new CEO Dr Juho Jalkanen sets bold vision for 2024	08/05	AQ
Update on financial status	30/04	AQ
Board Change	30/04	AQ
Faron Pharmaceuticals Oy - Insider Information, Appointment of Chief Financial Officer	16/04	AQ
Faron confirms plans under new leadership	16/04	AQ
Faron Confirms Plans for the Coming Months Under New Leadership	16/04	AQ
Appointment of Chief Financial Officer	15/04	AQ
Approval of Warrant Terms and Conditions	08/04	AQ
Decisions of the Board of Directors	08/04	AQ
Appointment of Chief Executive Officer	08/04	AQ
Results of the Annual General Meeting	05/04	AQ
Announcement of Placing	04/04	AQ

Aucun résultat pour cette recherche